NASDAQ · Medical - Healthcare Information Services
Nutex Health Inc. (NUTX) Stock
$206.29
+0.62%
NASDAQ: NUTX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Why Nutex Health’s (NUTX) Microhospital Economics Put Reimbursement at the Center of Its Upside Case
Insider Monkey · Jul 7, 2026
B. Riley Initiates Coverage on Nutex Health With Buy Rating, $290 Price Target
MT Newswires · Jun 26, 2026
3 Undervalued Small Caps With Insider Action Across Regions
Simply Wall St. · Jun 2, 2026
Nutex Health NUTX Q1 2025 Earnings Transcript
Motley Fool · May 4, 2026
Nutex Health NUTX Q2 2025 Earnings Transcript
Motley Fool · May 4, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held29.06%
Institutions Held42.51%
Institutions Float Held59.93%
Peer Comparison
About Nutex Health Inc.
Nutex Health Inc. is led by CEO Thomas T. Vo, employs 800 people, headquartered in US, publicly traded since 2022.
Nutex Health Inc. (NUTX) stock trades at $206.29 with a market capitalization of $1.42B. The stock is valued at a price-to-earnings (P/E) ratio of 8.21, price-to-book of 3.75, price-to-sales of 1.75. Over the past 52 weeks the stock has ranged between $83.99 and $225.00, and currently trades 8.3% below its 52-week high.
On profitability, Nutex Health Inc. generates a return on equity (ROE) of 51.88% — well above the market average, a sign of a high-quality business, return on capital employed of 42.99%, an operating margin of 31.39%, a net profit margin of 21.25%.